Dibaj I, Neupane S, Mehlum L
Borderline Personal Disord Emot Dysregul. 2025; 12(1):8.
PMID: 40083026
PMC: 11905671.
DOI: 10.1186/s40479-025-00285-4.
Sheline Y, Thase M, Hembree E, Balderston N, Nitchie F, Batzdorf A
Mol Psychiatry. 2025; .
PMID: 40069356
DOI: 10.1038/s41380-025-02945-x.
Messak M, Abdelmageed A, Senbel A, Khattab Y, Mandour Y, Shaker O
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40067438
DOI: 10.1007/s00210-025-03932-3.
Kafashan M, Lebovitz L, Greenspan R, Zhao S, Kim T, Husain M
BMJ Open. 2025; 15(3):e098859.
PMID: 40054874
PMC: 11891538.
DOI: 10.1136/bmjopen-2025-098859.
Tan J, Gu L, Zhou Y, Wang C, Lan X, Zheng W
Front Psychiatry. 2025; 16:1498952.
PMID: 40041696
PMC: 11876371.
DOI: 10.3389/fpsyt.2025.1498952.
Lack of association between pretreatment glutamate/GABA and major depressive disorder treatment response.
Dai F, Wengler K, He X, Wang J, Yang J, Parsey R
Transl Psychiatry. 2025; 15(1):71.
PMID: 40025010
PMC: 11873289.
DOI: 10.1038/s41398-025-03292-9.
Machine Learning Models to Identify Individuals With Imminent Suicide Risk Using a Wearable Device: A Pilot Study.
Um J, Park J, Lee D, Ahn J, Baek J
Psychiatry Investig. 2025; 22(2):156-166.
PMID: 40017279
PMC: 11878142.
DOI: 10.30773/pi.2024.0257.
Clinical prediction model for transition to psychosis in individuals meeting At Risk Mental State criteria.
Bonnett L, Hunt A, Flores A, Tudur Smith C, Varese F, Byrne R
Schizophrenia (Heidelb). 2025; 11(1):29.
PMID: 40011470
PMC: 11865318.
DOI: 10.1038/s41537-025-00582-5.
Design and methods of the research unit 5187 PREACT (towards precision psychotherapy for non-respondent patients: from signatures to predictions to clinical utility) - a study protocol for a multicentre observational study in outpatient clinics.
Langhammer T, Unterfeld C, Blankenburg F, Erk S, Fehm L, Haynes J
BMJ Open. 2025; 15(2):e094110.
PMID: 40010810
PMC: 11865781.
DOI: 10.1136/bmjopen-2024-094110.
Long-Term Cognitive Outcomes of Esketamine Nasal Spray in Treatment-Resistant Depression: A Preliminary Report.
Sobreiro M, Silveira P, Cavenaghi V, da Costa L, de Souza B, Takahashi R
Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40005986
PMC: 11858642.
DOI: 10.3390/ph18020173.
The Impact of Seasonality on Mental Health Disorders: A Narrative Review and Extension of the Immunoseasonal Theory.
Modzelewski S, Naumowicz M, Suprunowicz M, Oracz A, Waszkiewicz N
J Clin Med. 2025; 14(4).
PMID: 40004649
PMC: 11856923.
DOI: 10.3390/jcm14041119.
Increased Interleukin-6 Levels in Responders with Treatment-Resistant Depression After Bright Light Therapy.
Kosanovic Rajacic B, Sagud M, Begic D, Nikolac Perkovic M, Kozmar A, Rogic D
Biomolecules. 2025; 15(2).
PMID: 40001598
PMC: 11852636.
DOI: 10.3390/biom15020295.
Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment.
Overton M, Sindi S, Basna R, Elmstahl S
Alzheimers Dement (Amst). 2025; 17(1):e70093.
PMID: 39996036
PMC: 11848587.
DOI: 10.1002/dad2.70093.
Circulating Stress Hormones, Brain Health, and Cognition in Healthy Older Adults: Cross-Sectional Findings and Sex Differences in Age-Well.
Liebscher M, White S, Hass S, Chocat A, Mezenge F, Landeau B
Biol Psychiatry Glob Open Sci. 2025; 5(2):100431.
PMID: 39990626
PMC: 11847304.
DOI: 10.1016/j.bpsgos.2024.100431.
Efficacy of psychotherapy versus pharmacotherapy, or their combination, in chronic depression: study protocol for a systematic review and network meta-analysis using aggregated and individual patient data.
Schramm E, Elsaesser M, Muller J, Kwarteng N, Evrenoglou T, Cuijpers P
BMJ Open. 2025; 15(2):e089356.
PMID: 39971604
PMC: 11840898.
DOI: 10.1136/bmjopen-2024-089356.
A Latent Profile Analysis of Psychosis Symptoms to Examine Distress and Depression as Pathways to Suicide Ideation Among Individuals in an Early Phase of Psychosis Illness.
Bornheimer L, Brdar N, Lapidos A, Kelter A, Miner C, Grogan-Kaylor A
Early Interv Psychiatry. 2025; 19(2):e70013.
PMID: 39966957
PMC: 11836237.
DOI: 10.1111/eip.70013.
Comparative Efficacy and Safety of Ketamine Versus Electroconvulsive Therapy in Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials.
Ma Z, Wu F, Zheng W
Psychiatr Q. 2025; .
PMID: 39964582
DOI: 10.1007/s11126-025-10121-1.
Breastfeeding interventions for preventing postpartum depression.
Lenells M, Uphoff E, Marshall D, Wilson E, Gustafsson A, Wells M
Cochrane Database Syst Rev. 2025; 2:CD014833.
PMID: 39963955
PMC: 11834143.
DOI: 10.1002/14651858.CD014833.pub2.
Ketamine effects on resting state functional brain connectivity in major depressive disorder patients: a hypothesis-driven analysis based on a network model of depression.
Recourt K, van Gerven J, Drenth N, van der Grond J, Nishigori K, van der Wee N
Front Neurosci. 2025; 19:1531375.
PMID: 39963257
PMC: 11830811.
DOI: 10.3389/fnins.2025.1531375.
Lumateperone for the Treatment of Major Depressive Disorder With Mixed Features or Bipolar Depression With Mixed Features: A Randomized Placebo-Controlled Trial.
Durgam S, Kozauer S, Earley W, Chen C, Huo J, Lakkis H
J Clin Psychopharmacol. 2025; 45(2):67-75.
PMID: 39946099
PMC: 11882193.
DOI: 10.1097/JCP.0000000000001964.